Improved graft function in liver-transplanted patients after partial splenic embolization: Reversal of splenic artery steal syndrome?

Clinical Transplantation

Volumn 20, Issue 4, 2006, Pages 517-523

  Bárcena, Rafael ^a   Moreno, Ana ^a   Foruny, José Ramón ^a   Moreno, Alberto ^a   Sánchez, Juan ^a   Gil Grande, Luis ^a   Blázquez, Javier ^a   Nuño, Javier ^a   Fortún, Jesús ^a   Rodriguez Gandía, Miguel Angel ^a   Otón, Elena ^a  

^a HOSPITAL RAMÓN Y CAJAL   (Spain)

Author keywords

Hepatitis C virus recurrence; Liver transplant; Partial splenic embolization; Pegylated interferon plus ribavirin; Splenicartery steal syndrome

Indexed keywords

ANALGESIC AGENT; BILIRUBIN; DIURETIC AGENT; ENOXAPARIN; PEGINTERFERON; PROTHROMBIN; RIBAVIRIN; VIRUS RNA;

ADULT; ARTERY DIAMETER; ARTERY STEAL SYNDROME; ARTICLE; ARTIFICIAL EMBOLISM; ASCITES; CHOLESTASIS; CLINICAL ARTICLE; DRUG SAFETY; GRAFT DYSFUNCTION; HEMATOLOGICAL PARAMETERS; HEPATITIS C; HEPATITIS C VIRUS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPERSPLENISM; INTERNATIONAL NORMALIZED RATIO; LIVER BIOPSY; LIVER FAILURE; LIVER FUNCTION; LIVER TRANSPLANTATION; MALE; MATHEMATICAL MODEL; MAXIMUM PERMISSIBLE DOSE; NAUSEA; NONHUMAN; PAIN; PORTAL VEIN THROMBOSIS; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROTEIN FUNCTION; RECURRENT VIRUS INFECTION; SCORING SYSTEM; SPLEEN ARTERY; SPLEEN INFARCTION; SPLEEN SIZE; TREATMENT OUTCOME; VOMITING;

ADULT; EMBOLIZATION, THERAPEUTIC; HEPACIVIRUS; HEPATITIS C; HUMANS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; RECURRENCE; SPLEEN; VASCULAR DISEASES; VIRAL LOAD;

EID: 33745618671     PISSN: 09020063     EISSN: 13990012     Source Type: Journal    
DOI: 10.1111/j.1399-0012.2006.00516.x     Document Type: Article

References (17)

1. Del Guercio LRM, Commaraswamyn RP, Feins NR, Wollman SB, State D. Pulmonary arteriovenous admixture and the hyperdynamic cardiovascular state in surgery for portal hypertension. Surgery 1964: 56: 57.
2. De Carlis L, Sansalone CV, Rondinara GF et al. Splenic artery steal syndrome after orthotopic liver transplantation: Diagnosis and treatment. Transplant Proc 1993: 4: 2594.
3. Uflacker R, Selby JB, Chavin K, Rogers J, Baliga P. Transcatheter splenic artery occlusion for treatment of splenic artery steal syndrome after orthotopic liver transplantation. Cardiovasc Intervent Radiol 2002: 25: 300.
4. Nussler NC, Settmacher U, Haase R, Stange B, Heise M, Neuhaus P. Diagnosis and treatment of arterial steal syndromes in liver transplant recipients. Liver Transpl 2003: 9: 596.
5. Berenguer M, Ferrell L, Watson J et al. HCV-related fibrosis progression following liver transplantation: Increase in recent years. J Hepatol 2000: 32: 673.
6. Forman LM, Lewis JD, Berlin JA, Feldman HI, Lucey MR. The association between hepatitis C infection and survival after orthotopic liver transplantation. Gastroenterology 2002: 122: 889.
7. Sangro B, Bilbao I, Herrero I et al. Partial splenic embolization for the treatment of hypersplenism in cirrhosis. Hepatology 1993: 18: 309.
8. http://www.unos.org/resources/MeldPeldCalculator.asp?index=98 Accessed April 7, 2006.
9. Machalek L, Holibkova A, Tuma J, Houserkova D. The size of the splenic hilus, diameter of the splenic artery and its branches in the human spleen. Acta Univ Palacki Olomuc Fac Med 1998: 141: 45.
10. Quereda C, Moreno S, Moreno L et al. The role of liver biopsy in the management of chronic hepatitis C in patients infected with the human immunodeficiency virus. Hum Pathol 2004: 35: 1083.
11. Bárcena R, Gil-Grande L, Moreno J et al. Partial splenic embolization for the treatment of hypersplenism in liver transplanted patients with hepatitis C virus recurrence before peg-Interferon plus ribavirin. Transplantation 2005: 79: 1634.
12. Palsson B, Hallen M, Mandahl Forsberg A, Alwmark A. Partial splenic embolization: Long-term outcome. Langenbecks Arch Surg 2003: 387: 421.
13. Sakata K, Hirai K, Tanikawa K. A long-term investigation of transcatheter splenic arterial embolization for hypersplenism. Hepatogastroenterology 1996: 43: 309.
14. Tajiri T, Onda M, Yoshida H, Mamada Y, Taniai N, Kumazaki T. Long-term hematological and biochemical effects of partial splenic embolization in hepatic cirrhosis. Hepatogastroenterology 2002: 49: 1445.
15. Murata K, Shiraki K, Takse K, Nakano T, Tameda Y. Long term follow-up for patients with liver cirrhosis after partial splenic embolization. Hepatogastroenterology 1996: 43: 1212.
16. Babatin M, Schindel L, Burak KW. Pegylated-interferon alpha 2b and ribavirin for recurrent hepatitis C after liver transplantation: From a Canadian experience to recommendations for therapy. Can J Gastroenterol 2005: 19: 359.
17. Moreno A, Bárcena R, García-Garzón S et al. HCV clearance and treatment outcome in genotype 1 HCV-monoinfected, HIV co-infected and liver transplanted patients on peg-IFN-alfa-2b/ ribavirin. J Hepatol 2005: 43: 783.